| 摘要 |
<p>Present invention relates to pharmaceutical compositions comprising a third generation cephalosporin selected from a group comprising cefdinir, cefixime and cefpodoxime proxetil and clavulanic acid and/or pharmaceutically acceptable salts, hydrates, enantiomers, racemates, organic salts, inorganic salts, esters, polymorphs, crystal forms and amorphous forms and/or combinations thereof for use in the treatment of infections caused by resistant bacteria.</p> |
